Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03526887
Title Re-challenge Pembrolizumab Study as a Second or Further Line in Patients With Advanced NSCLC (Replay)
Acronym Replay
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Spanish Lung Cancer Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries ESP

Facility Status City State Zip Country Details
Hospital General Universitario de Elche Elche Alicante 03203 Spain Details
H. Germans Trias i Pujol Badalona Barcelona 08916 Spain Details
Hospital Parc Taulí Sabadell Barcelona 08208 Spain Details
Consorci Sanitari de Terrassa Terrassa Barcelona 08227 Spain Details
Complejo Hospitalario de la Coruña La Coruña Coruña 15006 Spain Details
Clínica Universidad de Navarra Pamplona Navarra 31008 Spain Details
Hospital de Basurto Bilbao Vizcaya 48013 Spain Details
Hospital de Santa Creu i Sant Pau Barcelona 08025 Spain Details
H.U.Vall D´Hebrón Barcelona 08035 Spain Details
Hospital Dr. Josep Trueta Girona 17007 Spain Details
Complejo Hospitalario de Jaén Jaén 23007 Spain Details
Complejo Asistencial Universitario de León León 24071 Spain Details
Fundación Jiménez Díaz Madrid 28040 Spain Details
H. 12 de Octubre Madrid 28041 Spain Details
Puerta de Hierro Madrid Spain Details
H. Son Llàtzer Palma de Mallorca 07198 Spain Details
Hospital General Universitario de Valencia Valencia 46014 Spain Details
Hospital La Fe Valencia 46026 Spain Details
Hospital Miguel Servet Zaragoza 50009 Spain Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field